Review of Antiplatelet Therapy for the Management of Acute Coronary Syndromes
Dear editor, Currently, cardiovascular diseases are the most common cause of morbidity and mortality in worldwide. Acute coronary syndromes (ACS) form a significant percentage of this disease spectrum. ACS encompasses non-ST-segment elevation myocardial infarction (NSTEMI), STEMI, and unstable angin...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ADICHUNCHANAGIRI INSTITUTE OF MEDICAL SCIENCES
2016-10-01
|
| Series: | Journal of Medical Sciences and Health |
| Subjects: | |
| Online Access: | http://www.jmsh.ac.in/index.php?option=com_k2&view=item&id=62:review-of-antiplatelet-therapy-for-the-management-of-acute-coronary-syndromes&Itemid=76 |
| Summary: | Dear editor, Currently, cardiovascular diseases are the most common cause of morbidity and mortality in worldwide. Acute coronary syndromes (ACS) form a significant percentage of this disease spectrum. ACS encompasses non-ST-segment elevation myocardial infarction (NSTEMI), STEMI, and unstable angina. The basic pathophysiology of ACS comprises plaque rupture with subsequent activation of the coagulation cascade, resulting in thrombus formation, and partial or complete occlusion of the coronary artery. There have been significant improvements in the treatment options and prognosis in ACS patients in the last couple of decades. Antiplatelets play a key role in the management of these patients, and this review focuses on the acute and long- term antiplatelet therapy for ACS patients. |
|---|---|
| ISSN: | 2394-9481 2394-949X |